ducted. The study population included CB patients aged Ն40 with Ն2 years continuous enrollment in the HIRD, Ն1 inpatient (INPT) admission/emergency department (ED) visit or Ն2 outpatient visits with CB (ICD-9-CM 491.xx) during the period from January 1, 2004 to May 31, 2011, and Ն2 pharmacy fills for COPD medications (the first fill served as the index date). CB patients were followed for 1 year to collect all-cause and COPD-related (ICD-9 codes: 491.xx, 492.xx, 496.xx) health care resource utilization (HCRU) and costs. Generalized Linear Models (GLM) with gamma distribution and log link function were utilized to identify HCRU cost predictors. RESULTS: A total of 17,382 treated CB patients met inclusion/exclusion criteria (50.6% female, mean age 66.7Ϯ11.4 years). During follow-up year, the mean number of COPD maintenance medication fills was 7.6Ϯ6.3; all-cause HCRU was: 39% had Ն 1 INPT, 26.6% had Ն 1 ED visits, and 98.4% had Ն 1 office visits; and mean total all-cause HCRU cost was $25,747Ϯ $51,105. COPD-related HCRU was: 32.6% had Ն 1 INPT, 12.9% had Ն 1 ED visits, and 81.8% had Ն1 office visits; mean total COPD-related HCRU cost was $12,609Ϯ$36,801. GLM models showed that baseline incidence of COPD exacerbations was a significant predictor of both all-cause (␤ϭ0.0924, pϽ0.0001) and COPD-related (␤ϭ0.1862, pϽ0.0001) HCRU costs during follow-up. Other significant predictors of follow-up COPD-related costs included Deyo-Charlson Index (␤ϭ0.1370, pϽ0.0001), female gender (␤ϭ -0.1280, pϽ0.0001), and age (␤ϭ0.0084, pϽ0.0001). CONCLUSIONS: HCRU and costs among CB patients treated with COPD maintenance medications were considerable during follow-up. New medications and disease management interventions aiming to reduce HCRU and costs among CB patients warrant exploration. 
OBJECTIVES:
Inhaled corticosteroids (ICSs) and long-acting beta-agonists (LABAs) have been recommended for patients with moderate to severe persistent asthma. This study quantified medication possession ratios (MPRs) for those asthmatic patients and assessed the association between severe asthma exacerbations (SAEs) and degree of medication compliance. METHODS: The primary data source was the MarketScan Multistate Medicaid database from 2002 to 2007. A total of 299,917 patients (ages 0-64) with moderate or severe asthma were selected. Drug use was tracked for ICSs, LABAs, ICS/LABA combination drugs, short-acting beta agonists leukotriene modifiers, and oral and IV steroids. An ICS-and-LABA MPR was calculated as the sum of days' supply for ICS and LABA drugs divided by the number of follow-up days during the first year after the patient's asthma index date. Logistic regressions were used to assess the risk of SAEs associated with degree of medication compliance. RESULTS: There were 21,852 (7.3%) patients with severe persistent and 278,065 (92.7%) patients with moderate persistent asthma. Within 12 months after asthma index date, average MPRs were 0.23 (median 0.14) for ICSs and LABAs and 0.66 (median 0.46) across all asthma medications. After controlling for covariates like age, gender, race, and comorbidities, the odds ratios of an asthmarelated emergency department (ED) visit was 0.81 (0.79-0.84) for a higher ICS-and-LABA MPR, but the odds ratio of asthma-related hospitalization or intubation was 1.56 (1.50-1.62). Other key risk factors (pϽ0.0001) included being African American, having an alcohol/substance abuse disorder, pregnancy, obesity, and upper respiratory tract infection. CONCLUSIONS: A higher ICS-and-LABA MPR appears to be associated with a lower risk of asthma-related ED visits, but higher risk of asthmarelated hospitalization or intubation. Certain patients with asthma, such as pregnant adolescents and African Americans, seem particularly vulnerable to SAEs. OBJECTIVES: Sub-optimal beliefs about chronicity of asthma may interfere with adherence to therapy and result in poor asthma control. Objective of the study was to characterize the beliefs about the chronicity of asthma and determine its association with medication adherence and self-management in asthma patients. METHODS: Adult patients (nϭ166) with previously diagnosed persistent asthma visiting emergency room (March 2009-December 2009) of a public chest hospital of Delhi for asthma exacerbation completed interviewer-administered questionnaire on socio-demographics, clinical history, disease beliefs, use of inhaled corticosteroids (ICS), and self-management of asthma after stabilization of their condition. RESULTS: The cohort had 54% patients in the age group of 30-40 years, 64% females, 11% illiterate, and 65% patients earning less than INR 10,000/month. Overall 87% patients believed that they had asthma when they are having symptoms, which is called as no symptoms, no asthma belief. No association was found between no symptoms, no asthma belief with gender, income, family history of asthma and co-morbidity. Younger patients in the age group 18-29 years had four to fivefold greater odds and patients with education above 10th grade had three to fourfold greater odds of having the no symptoms, no asthma belief or the acute episodic belief. Acute episodic belief was negatively associated with beliefs about always having asthma, asthma being a serious condition, having lung inflammation, or the importance of using ICS, and was positively associated with expecting to be cured (pϽ0.05). All patients irrespective of their belief of acute or chronic nature of asthma had poor adherence to the treatment and other self-management behaviors. CONCLUSIONS: Majority of the asthma patients believed asthma as acute episodic disease and had sub-optimal information about asthma. These beliefs need to be addressed by providing asthma education leading to medication adherence and asthma control. 
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OBJECTIVES:
Non-adherence to a prescribed therapeutic program is an issue in the treatment of chronic diseases more so for asthma, in which the lack of symptoms may be interpreted as remission and beliefs about inhaled corticosteroid (ICS) could also result in non-adherence. The objective of the study was to analyse the self-reported adherence to ICS therapy and beliefs about medicine. METHODS: Adult patients previously diagnosed with asthma and who were prescribed ICS, visiting emergency room of a tertiary care public chest hospital for asthma exacerbation were recruited (March 2008-December 2009). Patients completed self-reported questionnaire containing 49 questions on 6 domains: socio-demographic, clinical profile, causal belief, self-report on adherence, beliefs about medicines and medication adherence report scale (MARS) after stabilization. RESULTS: Of the 200 patients, 51.5% were between 30-40 years, 64% were female, mean duration of asthma was 10.5Ϯ8.1 years and 51.5% were having severe asthma. Salient findings on self-report adherence were, 49% reported that they took ICS even if asymptomatic; 91% reported that they forgot to take their ICS some or most of the times; 84% reported that they avoided ICS some of the times. In response to individual item for MARS, 15.5% claimed that they took ICS as prescribed. Significant positive correlation was observed between treatment necessity and reported adherence (rϭ0.445, p Ͻ 0.001). Patients who were concerned for the potential effects and risk of dependence had low adherence with significantly negative correlation. Younger age group had a significant correlation with social inhibition and female gender correlated significantly with fear of adverse effects and social inhibition as the cause for avoiding ICS. CONCLUSIONS: The findings support the model of treatment adherence, which incorporated beliefs about treatment as well as illness perceptions. The necessary-concerns offer a potentially useful framework to help clinicians elicits key treatment beliefs influencing adherence to ICS.
PRS33 THE EFFECT OF ADHERENCE TO COMBINATION THERAPY OF LONG ACTING BETA AGONIST AND INHALED CORTICOSTEROID (LABA ؉ ICS) ON EMERGENCY DEPARTMENT (ED) UTILIZATION IN NEWLY DIAGNOSED ASTHMA PATIENTS
Chung J, Nichol MB University of Southern California, Los Angeles, CA, USA OBJECTIVES: Asthma is a chronic inflammatory disorder of the airways and the prevalence of asthma has been increasing since the early 1980 across all age, gender and racial groups. Current asthma treatment guidelines suggest combination therapy of inhaled corticosteroid(ICS) and long acting beta agonist(LABA) for management of moderate to severe asthma. The primary objective was to identify effects of adherence to combination therapy of LABA and ICS(LABAϩICS) on emergency department(ED) utilization in newly diagnosed asthma patients. The secondary objective was to identify and use instrumental variables(IVs) to control for sample selection bias. METHODS: A de-identified patient claims nationwide commercial database was used to identify 7171 patients who were newly diagnosed with asthma. Patient adherence to LABAϩICS was measured using Medication Possession Ratio(MPR) with two years follow-up. IVs including medication copay and a binary indicator variable for mail prescription order were tested for overidentification and endogeneity using Sargan test and Hausman specification test. Differences in ED visit by MPR and adherence group(PoorϭMPRϽ80%, GoodϭMPRՆ80%) were analyzed by Cox proportional hazards model with a linear transformation. RESULTS: Patients with good adherence were significantly older than poor adherent patients(52 years vs. 48 years, pϽ0.05) and had significantly higher proportion of mail prescription order as well as medication copay. Every 1% increase in MPR was associated with a risk of approximately 4% of having an ED visit(HRϭ3.72, pϽ0.001) and the risk association for bivariate variable MPR increased from 79% to a two-fold while controlling for gender, age, and comorbidities(HRϭ2.03, pϽ0.001). Only one instrument of proportion of prescription mail order was accepted as the valid instrument and the results demonstrated that every 1% increase in MPR was significantly associated with 4.9% of risk in utilizing ED while holding other covariates constant(pϽ0.001). CONCLUSIONS: We found a risk association between high adherence and ED utilization in newly diagnosed asthma patients with LABAϩICS. 
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